Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Is Plug Power an Opportunity or a Warning?

By Josh Enomoto, InvestorPlace Contributor

Based on the science, fuel-cell technologies perform well under inclement weather, which should bode well for PLUG stock. With shares obviously printing red ink, is this an opportunity or a warning?

7 Stocks to Buy That Are Cheering for March Madness

By Josh Enomoto, InvestorPlace Contributor

A lesser-known fact is that the market tends to perform better during March Madness. If that’s the case this year, here are the stocks to buy.

Social Capital Hedosophia Holdings VI Is No Easy Wager

By Josh Enomoto, InvestorPlace Contributor

IPOF stock appeals thanks to track record of its leader, Chamath Palihapitiya. But don’t let this be the only reason to buy it.

Clovis Oncology Survived One Crisis Only to Face Another

By Josh Enomoto, InvestorPlace Contributor

CLVS stock should attract buyers because declining coronavirus cases offer more opportunities to serve cancer patients. But the economic narrative confirms that the bears may have a point in their pessimism.

Nano-X Imaging Has the Right Science at the Wrong Time

By Josh Enomoto, InvestorPlace Contributor

On one hand, NNOX stock is supported by a groundbreaking medical innovations. But on the other, economic problems present severe headwinds.

Load More